A study led by ICN2 and the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) has developed a neural interface that brings together two graphene-based technologies in a single device, with the potential to improve current approaches to modulating brain activity. This advance could be key to developing future therapies for conditions such as epilepsy and brain damage.